Document is current
Any future updates will be listed below
-
Authors
Dibble, Christian C. https://orcid.org/0000-0002-1122-9017
Barritt, Samuel A. https://orcid.org/0000-0002-3241-1272
Perry, Grace E. https://orcid.org/0000-0002-0404-9237
Lien, Evan C.
Geck, Renee C. https://orcid.org/0000-0001-7812-7675
DuBois-Coyne, Sarah E.
Bartee, David https://orcid.org/0000-0001-8090-4242
Zengeya, Thomas T.
Cohen, Emily B.
Yuan, Min
Hopkins, Benjamin D. https://orcid.org/0000-0002-7970-6430
Meier, Jordan L.
Clohessy, John G. https://orcid.org/0000-0001-5186-9775
Asara, John M.
Cantley, Lewis C. https://orcid.org/0000-0002-1298-7653
Toker, Alex https://orcid.org/0000-0003-0723-4419
- License Information
-
More Information
Article History
Received: 25 February 2021
Accepted: 16 June 2022
First Online: 27 July 2022
Competing interests
: L.C.C. is a founder and scientific advisory board member of Agios Pharmaceuticals, Faeth Therapeutics, Petra Pharma Corporation, Larkspur Therapeutics and Volastra Pharmaceuticals, and scientific advisory board member for Scorpion Therapeutics. B.D.H. is a co-founder of and consultant for Faeth Therapeutics.
